Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: adapt (132), adjust (315), alter (499), change (1000), amend (105), vary (326), moderate (327)

1607TalimogeneRx108PFU (2)

Description: TALIMOGENE 108PFU/ml for MELANOMA INITIAL PRESCRIPTION – Second and Subsequent ADMINISTRATIONS ONLY Please Attach Addressograph Patient Information Card Yes / No (please
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/1607TalimogeneRx108PFU-2.pdf

1607TalimogeneRx106PFU (2)

Description: TALIMOGENE 106 PFU/ml for MELANOMA INITIAL PRESCRIPTION – FIRST ADMINISTRATION ONLY Please Attach Addressograph Patient Information Card Yes / No (please circle
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/1607TalimogeneRx106PFU-2.pdf

Cetuximab-Fluorouracil-Folinic Acid-Oxaliplatin

Description: Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB-FLUOROURACIL-FOLINIC ACID (Modified de Gramont)OXALIPLATIN Regimen • Colorectal Cancer – Cetuximab-Fluorouracil-Folinic Acid (modified de
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab-Fluorouracil-FolinicAcid-Oxaliplatin.pdf

Virtual consultation, actual peril

Description: A court considers whether a virtual consultation is sufficient for assessing a patient's mental health.
Url: /HealthProfessionals/Clinical-law-updates/Virtual-consultation-actual-peril.aspx

UHS AR 23-24 Final

Description: 2023/24 Incorporating the quality account University Hospital Southampton NHS Foundation Trust Annual Report and Accounts 2023/24 Presented to Parliament
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/UHS-AR-23-24-Final.pdf

Annual report 2021-2022

Description: 2021/22 Incorporating the quality report University Hospital Southampton NHS Foundation Trust Annual Report and Accounts 2021/22 Presented to Parliament
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/Annual-report-2021-2022.pdf

Diabetes: managing your foot wound - patient information

Description: You have been given this factsheet to help you recover from your foot ulcer or recent foot surgery. Please keep it
Url: /Media/UHS-website-2019/Patientinformation/Diabetes/Diabetes-managing-your-foot-wound-1473-PIL.pdf

Bleomycin-Cisplatin-Etoposide (3 day-Mod-BEP) Ver1.2

Description: Chemotherapy Protocol GERM CELL BLEOMYCIN-CISPLATIN-ETOPOSIDE (BEP 3 Day Modified) Regimen Germ Cell – Bleomycin-Cisplatin-Etoposide (3 day-Mod-BEP
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/Bleomycin-Cisplatin-Etoposide-3-day-Mod-BEP-Ver1.2.pdf

Cisplatin-Gemcitabine Version 1.2

Description: Chemotherapy Protocol BILIARY TRACT CANCER CISPLATIN-GEMCITABINE Regimen Biliary Tract Cancer – Cisplatin-Gemcitabine Indic
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Cisplatin-Gemcitabine-Version-12.pdf

Following a soft food diet after a gastrectomy or oesophagectomy - patient information

Description: Your doctors have recommended that you follow a soft food diet after having your gastrectomy or oesophagectomy operation.
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Following-a-soft-food-diet-after-a-gastrectomy-or-oesophagectomy-1267-PIL.pdf

21 to 30 of 121

Previous 1 2 3 4 5 … Next